Ozempic and other drugs like it have been threatening the more traditional weight loss industry since they premiered — and it appears that Weight Watchers is the first to get the hatchet. In a note to investors,

Once boasting up to five million subscribers and backed by the likes of Oprah Winfrey, the company is now trying to shed debt and restructure